Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00616369 · ClinicalTrials.gov registry record
Identification of Genetic Markers for Cardiopulmonary Diseases (Genotype)
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 255
- Enrollment target
NCT00616369 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 255 participants.
The verdict
NCT00616369 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 255 participants
- Enrollment target
Study Summary
This study is designed to investigate whether an association exists between certain genes/protein levels and the development of various cardiopulmonary diseases. It is hoped that this project will provide valuable insight into the understanding of these diseases.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2008-01 |
| Est. Completion | 2015-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00616369
The ClinicalTrials.gov registry entry for NCT00616369 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 255 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00616369 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00616369 about?
NCT00616369 is a clinical study titled "Identification of Genetic Markers for Cardiopulmonary Diseases (Genotype)". This study is designed to investigate whether an association exists between certain genes/protein levels and the development of various cardiopulmonary diseases. It is hoped that this project will provide valuable insight into the understanding of these diseases.
What is the current status of trial NCT00616369?
This trial is currently completed. The enrollment target is 255 participants. The study started on 2008-01. Estimated completion is 2015-01.
Who is sponsoring clinical trial NCT00616369?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.